Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience.
Pérez Ramírez S, Del Monte-Millán M, López-Tarruella S, Martínez Jáñez N, Márquez-Rodas I, Lobo Samper F, Izarzugaza Perón Y, Rubio Terres C, Rubio Rodríguez D, García-Sáenz JÁ, Moreno Antón F, Zamora Auñón P, Arroyo Yustos M, Lara Álvarez MÁ, Ciruelos Gil EM, Manso Sánchez L, Echarri González MJ, Guerra Martínez JA, Jara Sánchez C, Bueno Muiño C, García Adrián S, Carrión Galindo JR, Valentín Maganto V, Martín M. Pérez Ramírez S, et al. Clin Transl Oncol. 2020 May;22(5):717-724. doi: 10.1007/s12094-019-02176-x. Epub 2019 Jul 12. Clin Transl Oncol. 2020. PMID: 31300934
Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice.
Vicente-Valor J, Escudero-Vilaplana V, Collado-Borrell R, Pérez-Ramírez S, Villanueva-Bueno C, Narrillos-Moraza Á, García-Sánchez S, Beamud-Cortés M, Herranz A, Sanjurjo M. Vicente-Valor J, et al. Among authors: perez ramirez s. Expert Opin Drug Metab Toxicol. 2021 Dec;17(12):1467-1473. doi: 10.1080/17425255.2021.2027908. Epub 2022 Jan 21. Expert Opin Drug Metab Toxicol. 2021. PMID: 35001772
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy.
Ramos-Ruperez E, Escudero-Vilaplana V, Ruiz-Briones P, Collado-Borrell R, Villanueva-Bueno C, Revuelta-Herrero JL, González-Haba E, Garcia-Gonzalez X, Ibañez-Garcia S, Perez-Ramirez S, Zatarain-Nicolás E, Herranz A, Sanjurjo M. Ramos-Ruperez E, et al. Among authors: perez ramirez s. Front Oncol. 2023 Aug 25;13:1220305. doi: 10.3389/fonc.2023.1220305. eCollection 2023. Front Oncol. 2023. PMID: 37692846 Free PMC article.
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.
Kraaijpoel N, Bleker SM, Meyer G, Mahé I, Muñoz A, Bertoletti L, Bartels-Rutten A, Beyer-Westendorf J, Porreca E, Boulon C, van Es N, Iosub DI, Couturaud F, Biosca M, Lerede T, Lacroix P, Maraveyas A, Aggarwal A, Girard P, Büller HR, Di Nisio M; UPE investigators. Kraaijpoel N, et al. J Clin Oncol. 2019 Jul 10;37(20):1713-1720. doi: 10.1200/JCO.18.01977. Epub 2019 May 22. J Clin Oncol. 2019. PMID: 31116676